1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Primers
1.2.3 Probes
1.2.4 Intermediate-scale Synthesis Oligos
1.2.5 Large-scale Synthesis Oligos
1.2.6 Linkers and Adaptors
1.3 Market by Application
1.3.1 Global Solid-phase Oligonucleotide Synthesis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Solid-phase Oligonucleotide Synthesis Market Perspective (2017-2028)
2.2 Solid-phase Oligonucleotide Synthesis Growth Trends by Region
2.2.1 Solid-phase Oligonucleotide Synthesis Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Solid-phase Oligonucleotide Synthesis Historic Market Size by Region (2017-2022)
2.2.3 Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Region (2023-2028)
2.3 Solid-phase Oligonucleotide Synthesis Market Dynamics
2.3.1 Solid-phase Oligonucleotide Synthesis Industry Trends
2.3.2 Solid-phase Oligonucleotide Synthesis Market Drivers
2.3.3 Solid-phase Oligonucleotide Synthesis Market Challenges
2.3.4 Solid-phase Oligonucleotide Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue
3.1.1 Global Top Solid-phase Oligonucleotide Synthesis Players by Revenue (2017-2022)
3.1.2 Global Solid-phase Oligonucleotide Synthesis Revenue Market Share by Players (2017-2022)
3.2 Global Solid-phase Oligonucleotide Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Solid-phase Oligonucleotide Synthesis Revenue
3.4 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio
3.4.1 Global Solid-phase Oligonucleotide Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid-phase Oligonucleotide Synthesis Revenue in 2021
3.5 Solid-phase Oligonucleotide Synthesis Key Players Head office and Area Served
3.6 Key Players Solid-phase Oligonucleotide Synthesis Product Solution and Service
3.7 Date of Enter into Solid-phase Oligonucleotide Synthesis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid-phase Oligonucleotide Synthesis Breakdown Data by Type
4.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Type (2017-2022)
4.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Type (2023-2028)
5 Solid-phase Oligonucleotide Synthesis Breakdown Data by Application
5.1 Global Solid-phase Oligonucleotide Synthesis Historic Market Size by Application (2017-2022)
5.2 Global Solid-phase Oligonucleotide Synthesis Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
6.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type
6.2.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
6.2.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
6.2.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
6.3 North America Solid-phase Oligonucleotide Synthesis Market Size by Application
6.3.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
6.3.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
6.3.3 North America Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
6.4 North America Solid-phase Oligonucleotide Synthesis Market Size by Country
6.4.1 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
6.4.2 North America Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
7.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type
7.2.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
7.2.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
7.2.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
7.3 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application
7.3.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
7.3.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
7.3.3 Europe Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
7.4 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country
7.4.1 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
7.4.2 Europe Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
8.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type
8.2.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
8.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application
8.3.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
8.4 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region
8.4.1 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Solid-phase Oligonucleotide Synthesis Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
9.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type
9.2.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
9.2.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
9.2.3 Latin America Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
9.3 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application
9.3.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
9.3.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
9.3.3 Latin America Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
9.4 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country
9.4.1 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
9.4.2 Latin America Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size (2017-2028)
10.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type
10.2.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Type (2017-2028)
10.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application
10.3.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Share by Application (2017-2028)
10.4 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country
10.4.1 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Solid-phase Oligonucleotide Synthesis Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Genescript
11.1.1 Genescript Company Details
11.1.2 Genescript Business Overview
11.1.3 Genescript Solid-phase Oligonucleotide Synthesis Introduction
11.1.4 Genescript Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.1.5 Genescript Recent Developments
11.2 GeneArt (Thermofischer)
11.2.1 GeneArt (Thermofischer) Company Details
11.2.2 GeneArt (Thermofischer) Business Overview
11.2.3 GeneArt (Thermofischer) Solid-phase Oligonucleotide Synthesis Introduction
11.2.4 GeneArt (Thermofischer) Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.2.5 GeneArt (Thermofischer) Recent Developments
11.3 Renesas Electronics Corporation
11.3.1 Renesas Electronics Corporation Company Details
11.3.2 Renesas Electronics Corporation Business Overview
11.3.3 Renesas Electronics Corporation Solid-phase Oligonucleotide Synthesis Introduction
11.3.4 Renesas Electronics Corporation Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.3.5 Renesas Electronics Corporation Recent Developments
11.4 DNA 2.0 (ATUM)
11.4.1 DNA 2.0 (ATUM) Company Details
11.4.2 DNA 2.0 (ATUM) Business Overview
11.4.3 DNA 2.0 (ATUM) Solid-phase Oligonucleotide Synthesis Introduction
11.4.4 DNA 2.0 (ATUM) Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.4.5 DNA 2.0 (ATUM) Recent Developments
11.5 OriGene
11.5.1 OriGene Company Details
11.5.2 OriGene Business Overview
11.5.3 OriGene Solid-phase Oligonucleotide Synthesis Introduction
11.5.4 OriGene Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.5.5 OriGene Recent Developments
11.6 BBI
11.6.1 BBI Company Details
11.6.2 BBI Business Overview
11.6.3 BBI Solid-phase Oligonucleotide Synthesis Introduction
11.6.4 BBI Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.6.5 BBI Recent Developments
11.7 Genewiz
11.7.1 Genewiz Company Details
11.7.2 Genewiz Business Overview
11.7.3 Genewiz Solid-phase Oligonucleotide Synthesis Introduction
11.7.4 Genewiz Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.7.5 Genewiz Recent Developments
11.8 Eurofins Genomics
11.8.1 Eurofins Genomics Company Details
11.8.2 Eurofins Genomics Business Overview
11.8.3 Eurofins Genomics Solid-phase Oligonucleotide Synthesis Introduction
11.8.4 Eurofins Genomics Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.8.5 Eurofins Genomics Recent Developments
11.9 Gene Oracle
11.9.1 Gene Oracle Company Details
11.9.2 Gene Oracle Business Overview
11.9.3 Gene Oracle Solid-phase Oligonucleotide Synthesis Introduction
11.9.4 Gene Oracle Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.9.5 Gene Oracle Recent Developments
11.10 SBS Genetech
11.10.1 SBS Genetech Company Details
11.10.2 SBS Genetech Business Overview
11.10.3 SBS Genetech Solid-phase Oligonucleotide Synthesis Introduction
11.10.4 SBS Genetech Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.10.5 SBS Genetech Recent Developments
11.11 Bio Basic
11.11.1 Bio Basic Company Details
11.11.2 Bio Basic Business Overview
11.11.3 Bio Basic Solid-phase Oligonucleotide Synthesis Introduction
11.11.4 Bio Basic Revenue in Solid-phase Oligonucleotide Synthesis Business (2017-2022)
11.11.5 Bio Basic Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer